Mel Sorensen - Mar 10, 2023 Form 4 Insider Report for Galera Therapeutics, Inc. (GRTX)

Role: President and CEO, Director
Signature: /s/ Chris Degnan, Attorney-in-Fact for J. Mel Sorensen
Stock symbol: GRTX
Transactions as of: Mar 10, 2023
Transactions value $: $168,120
Form type: 4
Date filed: 3/14/2023, 08:30 AM
Previous filing: Feb 28, 2023
Next filing: Aug 20, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GRTX	Common Stock	Purchase	$168K	+100K	+43.1%	$1.68^*	332K	Mar 10, 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.635 to $1.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.635 to $1.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.